logo

Stock Screener

Forex Screener

Crypto Screener

CC

The Chemours Company (CC)

$

15.07

-0.16 (-1.06%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

-0.2330

Market cap

Market cap

2.3 Billion

Price to sales ratio

Price to sales ratio

0.3838

Debt to equity

Debt to equity

1.0295

Current ratio

Current ratio

1.6757

Income quality

Income quality

-0.6595

Average inventory

Average inventory

1.6 Billion

ROE

ROE

-0.8089



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

The Chemours Company, founded in 2014 and headquartered in Wilmington, Delaware, provides performance chemicals across several global regions, including North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment specializes in TiO2 pigment under the Ti-Pure and BaiMax brands, which deliver essential properties such as whiteness, brightness, opacity, and protection across a range of applications, including architectural and industrial coatings, plastic packaging, and laminate papers. The Thermal & Specialized Solutions segment focuses on refrigerants, thermal management solutions, and foam blowing agents, while the Advanced Performance Materials portfolio contains industrial resins, specialty products, and coatings for various sectors, including consumer electronics and semiconductors. The Chemical Solutions segment offers industrial chemicals vital for multiple uses, such as gold production and water treatment. The company recorded an operating income of $458,000,000.00 reflecting its earnings from core operations. The weighted average number of shares outstanding is $149,494,000.00 highlighting the company's shareholder base. The financial data pertains to the fiscal year $2024 with operating expenses amounting to $708,000,000.00 showcasing the various costs incurred in operations. Additionally, the company earned an interest income of $0.00 illustrating its financial investments in diverse areas. In the investment landscape, the company's stock is affordable at $13.49 making it a suitable option for budget-conscious investors. It features a high average trading volume of 4,408,736.00 indicating strong liquidity that can support active trading strategies. With a mid-range market capitalization of $2,255,948,860.00 the company exemplifies steady performance within its sector. It is a key player in the Chemicals - Specialty industry, contributing significantly to the overall market landscape. Furthermore, it belongs to the Basic Materials sector, driving innovation and growth, which presents prospects for future developments that investors may find appealing.

What is The Chemours Company (CC)'s current stock price?

The current stock price of The Chemours Company (CC) is $15.16 as of 2025-08-29. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in The Chemours Company (CC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as D+, with a Bullish outlook. Always conduct your own research before investing.

Analysts predict The Chemours Company stock to fluctuate between $9.13 (low) and $22.38 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2025-08-29, The Chemours Company's market cap is $2,255,948,860, based on 149,698,000 outstanding shares.

Compared to The Sherwin-Williams Company, The Chemours Company has a Lower Market-Cap, indicating a difference in performance.

The Chemours Company pays dividends. The current dividend yield is 4.62%, with a payout of $0.09 per share.

To buy The Chemours Company (CC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CC. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.

Revenue: $5,782,000,000 | EPS: $0.58 | Growth: -136.25%.

Visit https://www.chemours.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $44.95 (2022-06-06) | All-time low: $9.13 (2025-06-02).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

CC

businesswire.com

Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Publishes 2024 Sustainability Report, Showcasing Latest Progress Against Its 2030 Goals.

CC

zacks.com

Chemours Enters Strategic Agreement With SRF to Boost Supply

CC partners with SRF to expand global supply chain, boost operational flexibility and strengthen its high-value product mix.

CC

businesswire.com

Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours and SRF Limited Announce Strategic Agreements in India to Support Market Needs for Essential Applications by 2026.

CC

businesswire.com

Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Samsung Electronics Successfully Qualifies Chemours' Opteon™ Two-Phase Immersion Cooling Fluid.

CC

zacks.com

Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes

CC posts Q2 earnings and sales beat driven by volume and pricing gains, but issues softer sequential guidance.

CC

seekingalpha.com

Chemours: Solid Q2 And Legal Progress Are Bullish (Rating Upgrade)

Chemours is showing financial improvement, especially in Opteon refrigerants, despite industry headwinds and a recent dividend cut. The company's legal overhang is easing after a favorable New Jersey PFAS settlement, freeing up future cash flow and reducing uncertainty. Balance sheet leverage remains high, but improving free cash flow in the second half should reduce net debt and support the current dividend.

CC

zacks.com

Chemours (CC) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CC

zacks.com

Chemours (CC) Tops Q2 Earnings and Revenue Estimates

Chemours (CC) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.38 per share a year ago.

CC

seekingalpha.com

Chemours: Refrigerants Make This Company A Buy Before Q2 2025 Report

Chemours is at a cyclical low, presenting a buying opportunity ahead of expected 2Q25 revenue growth. Despite legacy risks and sub-par credit, Chemours' leadership in low-impact refrigerants and proprietary titanium technology sets it apart from competitors. Current market and analyst sentiment underestimates Chemours' potential, with forecasts showing strong EPS and EBITDA growth through 2026-2027.

CC

reuters.com

Chemours, DuPont, Corteva to settle environmental claims with New Jersey

Chemours , DuPont and Corteva said on Monday they have reached an agreement with the state of New Jersey in various litigation matters including PFAS chemicals and other state directives.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener